These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8614294)

  • 21. [3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra.
    Löschmann PA; De Groote C; Albrecht C; Darstein M; Deransart C; Landwehrmeyer GB; Lücking CH; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):414-21. PubMed ID: 11330335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
    Lawler CP; Gilmore JH; Watts VJ; Walker QD; Southerland SB; Cook LL; Mathis CA; Mailman RB
    Synapse; 1995 Dec; 21(4):299-311. PubMed ID: 8869160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
    Nash JE; Brotchie JM
    Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.
    Coffeen PR; Efange SM; Haidet GC; McKnite S; Langason RB; Khare AB; Pennington J; Lurie KG
    Nucl Med Biol; 1996 Oct; 23(7):923-6. PubMed ID: 8971861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
    Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
    J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxic ventilatory response after dopamine D2 receptor blockade in unilateral rat model of Parkinson's disease.
    Andrzejewski K; Budzińska K; Zaremba M; Kaczyńska K
    Neuroscience; 2016 Mar; 316():192-200. PubMed ID: 26705738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?
    Biggs CS; Fowler LJ; Whitton PS; Starr MS
    Brain Res; 1997 Apr; 753(1):163-75. PubMed ID: 9125444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
    Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
    Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
    Ingvar M; Stone-Elander S; Rogers GA; Johansson B; Eriksson L; Parsons SM; Widén L
    Neuroreport; 1993 Sep; 4(12):1311-4. PubMed ID: 8260611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
    Bernard V; Gardiol A; Faucheux B; Bloch B; Agid Y; Hirsch EC
    J Comp Neurol; 1996 May; 368(4):553-68. PubMed ID: 8744443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of AP-1 DNA-binding activity by D1 and D2 dopamine receptor antagonists in the rat caudate-putamen and globus pallidus following a unilateral 6-OHDA lesion of the medial forebrain bundle.
    Kashihara K; Akiyama K; Ishihara T; Manabe Y; Abe K
    Neurol Res; 1999 Mar; 21(2):175-9. PubMed ID: 10100204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats.
    Rui G; Guangjian Z; Yong W; Jie F; Yanchao C; Xi J; Fen L
    Behav Brain Res; 2013 Jan; 237():263-9. PubMed ID: 23036843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.
    Zhen X; Torres C; Cai G; Friedman E
    Mol Pharmacol; 2002 Dec; 62(6):1356-63. PubMed ID: 12435803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model.
    Fatemi I; Abdollahi A; Shamsizadeh A; Allahtavakoli M; Roohbakhsh A
    Acta Neuropsychiatr; 2021 Feb; 33(1):15-21. PubMed ID: 32967746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.